Welltower Inc.
WELLReal Estate Reit Healthcare Facilities
Welltower Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.8 billion, up 35.6% from fiscal 2024.
- Revenue
- +38.4%
- EPS
- +31.7%
- Free cash flow
- +20.4%
- Total debt
- +13.9%
Quarter to September 2026, against a year earlier
After hours trading: 240.34, unchanged, last trade 4:04pm Eastern.
Follow WELL
Alert me
Welltower Inc. (WELL) P/S ratio
As of Nov 20, 2026, Welltower Inc. (WELL) trades at a P/S ratio of 12.6×. Over the past ten years it has ranged from 2.6× (March 2020) to 14.1× (November 2025); the current reading is higher than 94% of that period. That is above the Reit Healthcare Facilities industry median of 5.2× and above the Real Estate sector median of 2.7×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 11.4× | 19.87% |
| FY2024 | 9.5× | 35.66% |
| FY2023 | 7.0× | 32.76% |
| FY2022 | 5.3× | (31.31%) |
| FY2021 | 7.7× | 31.88% |
| FY2020 | 5.8× | (9.17%) |
| FY2019 | 6.4× | 16.31% |
| FY2018 | 5.5× | 1.28% |
| FY2017 | 5.4× | (1.63%) |
| FY2016 | 5.5× | (9.78%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 12.1× | (4.20%) |
| Jun 2026 | 12.6× | 7.33% |
| Mar 2026 | 11.8× | 3.15% |
| Dec 2025 | 11.4× | (5.71%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| DOC Healthpeak Properties, Inc. compare | 4.3× |
| AHR American Healthcare REIT, Inc. compare | 4.7× |
| SBRA Sabra Healthcare REIT, Inc. compare | 5.7× |
| HR Healthcare Realty Trust Incorporated compare | 5.8× |
| VTR Ventas, Inc. compare | 6.6× |
| NHI National Health Investors, Inc. compare | 6.6× |
| OHI Omega Healthcare Investors, Inc. compare | 10.6× |
| WELL Welltower Inc. | 12.6× |
| CTRE CareTrust REIT, Inc. compare | 14.4× |
| Reit Healthcare Facilities industry median | 5.2× |
| Real Estate sector median | 2.7× |
| Market median | 1.7× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on WELL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement